Ischemic Heart Disease Market is expected to grow at a moderate rate during the forecast period 2018-2023. Ischemic heart disease, also known as CHD (coronary heart diseases) and CAD (coronary artery disease) is caused by defect and damage in the heart. Silent ischemia is one of the most prevailing ischemic diseases across the globe, caused by heart attack without prior warning. Moreover, the people having previous heart attacks or have diabetes are more prone to silent ischemia. Unhealthy dietary habits such as excessive consumption of alcohol & tobacco and lack of exercise increase the risk of ischemic heart diseases around the globe.

Request a free sample of our report on Ischemic Heart Disease Drugs Market: https://www.omrglobal.com/request-sample/ischemic-heart-disease-market

Various pivotal factors that are augmenting the ischemic heart disease market includes growing incidence and prevalence rate of hypertension, high cholesterol, diabetes, and obesity across the globe. Government funding for diagnosis, treatment and research and their initiative programs to increase the awareness toward disease is another major factor augmenting the growth of the market. However, the high costs of treatment coupled with the regular uncertainty seen in reimbursement policies can hamper the growth of the market. Opportunities that are expected to augment the market includes increasing awareness among people towards the heart diseases and improving healthcare system and healthcare spending in emerging economies.

A full report of Ischemic Heart Disease Drugs Market Is available at https://www.omrglobal.com/industry-reports/ischemic-heart-disease-market

Global Ischemic Heart Diseases Market Segmentation

By Disease Type

Angina

Myocardial Infarction

Ischemic Stroke

By Diagnosis Method

Electrocardiogram (ECG)

Echocardiogram

Chest X-Ray

Cardiac Catheterization

Coronary Angiogram

By Treatment

Medication

NSAID

Statins

Beta Blocker

Calcium Channel Blocker

ACE Inhibitors

Others (Organic Nitrates)

Surgery

Coronary Stent

Angioplasty

COMPETITIVE LANDSCAPE

Key Strategy Analysis

Key Company Analysis

REGIONAL ANALYSIS

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

RoE

Asia-Pacific

India

China

Japan

Rest of Asia-Pacific

Rest of the World (RoW)

COMPANY PROFILES

Abbott Laboratories

Amgen Inc.

AstraZeneca PLC

Bayer AG

Boston Scientific Corp.

Cardinal Health, Inc.

Daiichi Sankyo Co. Ltd.

Edwards Lifesciences Corp.

General Electric Co.

Genentech, Inc.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/ischemic-heart-disease-market

About Us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.



For More Information, Visit https://www.omrglobal.com/



Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404